2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Wilson Disease: new trials by email Literature Review of Wilson Disease trials Research Report on Wilson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease Penicillamine (D1-W12), TETA 4HCL (W12-60), Penicillamine (W12-W60) - Wilson Disease | Phase 3 | Completed | Orphalan | 77 | 2018-09-03 | 2025-07-02 |
| Study of Tetrathiomolybdate in Patients With Wilson Disease tetrathiomolybdate, trientine - Wilson Disease | Phase 3 | Completed | National Center for Research Resources (NCRR) | 90 | 1994-01-01 | 2006-05-09 |
Hepatolenticular Degeneration (2) · Metabolism, Inborn Errors (1) · Rare Diseases (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Brain Diseases, Metabolic (2) · Brain Diseases, Metabolic, Inborn (2) · Central Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Liver Diseases (2) · Metabolic Diseases (2) · Metal Metabolism, Inborn Errors (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2)
Penicillamine (1) · Trientine (1) · tetrathiomolybdate (1)
National Center for Research Resources (NCRR) (1) · Orphalan (1)
United States (2) · Belgium (1) · Brazil (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · United Kingdom (1)
George J. Brewer (1)